LB Pharmaceuticals Inc (LBRX)

Currency in USD
30.48
-0.12(-0.39%)
Closed·
29.89-0.59(-1.94%)
·
LBRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
30.0531.93
52 wk Range
13.3633.47
Key Statistics
Prev. Close
30.6
Open
30.6
Day's Range
30.05-31.93
52 wk Range
13.36-33.47
Volume
295.03K
Average Volume (3m)
237.28K
1-Year Change
-
Book Value / Share
14.97
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LBRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
45.00
Upside
+47.64%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings upwards for the upcoming period

LB Pharmaceuticals Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 45.00
(+47.64% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy45.00+47.64%-Maintain22-06-2026
Clear Street
Buy45.00+47.64%-New Coverage26-05-2026
H.C. Wainwright
Buy45.00+47.64%-Maintain26-05-2026
H.C. Wainwright
Buy45.00+47.64%-New Coverage27-04-2026
Craig-Hallum
Buy36.00+18.11%-New Coverage10-04-2026

Earnings

Latest Release
12-05-2026
EPS / Forecast
-0.67 / -0.50
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

LBRX Income Statement

Compare LBRX to Peers and Sector

Metrics to compare
LBRX
Peers
Sector
Relationship
P/E Ratio
−22.4x−4.7x−0.4x
PEG Ratio
−0.23−0.210.00
Price/Book
2.3x−6.9x2.6x
Price / LTM Sales
-2.2x3.0x
Upside (Analyst Target)
26.3%94.3%55.7%
Fair Value Upside
Unlock16.8%8.1%Unlock

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 2 clinical trial for the treatment of bipolar I depression; adjunctive treatment of MDD; and in pre-clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5.92M20.65%176.82M
Other Institutional Investors
35.13M79.35%1.05B
Public Companies & Retail Investors
0.000.00%0.00
Total
41.05M100.00%1.23B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Deep Track Capital, LP11.69%33,52,8041,00,148
Deep Track Biotechnology Master Fund, Ltd9.37%26,86,13880,235

FAQ

What Is the LB Pharmaceuticals (LBRX) Share Price Today?

The LB Pharmaceuticals share price today is 30.48.

What is the current LB Pharmaceuticals (LBRX) share price and day range?

As of 25-06-2026, the LB Pharmaceuticals share price is 30.48, with a previous close of 30.60. The share price has ranged from 30.05 to 31.93 today, while the 52-week range spans from 13.36 to 33.47.

What Is the LB Pharmaceuticals Market Cap?

As of today, LB Pharmaceuticals market cap is 877.51M.

What Is the LB Pharmaceuticals (LBRX) Share Price Target?

The average 12-month share price target for LB Pharmaceuticals is 45.00, with a high estimate of 78 and a low estimate of 34. 6 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +47.64% Upside potential.

What Is LB Pharmaceuticals's Earnings Per Share (TTM)?

The LB Pharmaceuticals EPS (TTM) is -2.59.

When Is the Next LB Pharmaceuticals Earnings Date?

LB Pharmaceuticals will release its next earnings report on 02-09-2026.

From a Technical Analysis Perspective, Is LBRX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

What Stock Exchange Does LB Pharmaceuticals Trade On?

LB Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for LB Pharmaceuticals?

The stock symbol for LB Pharmaceuticals is "LBRX."

How Many Times Has LB Pharmaceuticals Stock Split?

LB Pharmaceuticals has split 0 times.

How Many Employees Does LB Pharmaceuticals Have?

LB Pharmaceuticals has 35 employees.

What Is the LBRX Premarket Price?

LBRX's last pre-market stock price is 30.11. The pre-market share volume is 120.00, and the stock has changed by -0.49, or -1.60%.

What Is the LBRX After Hours Price?

LBRX's last after hours stock price is 29.89, the stock has changed by -0.59, or -1.94%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.